Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
257.00    -3.00 (-1.15%)
Bid:
251.00
Ask:
257.00
Spread: 6.00 (2.39%)
Market Cap: £230.16m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Director/PDMR Shareholding

29 Oct 2012 14:19

RNS Number : 7753P
Wilmington Group Plc
29 October 2012
 



WILMINGTON GROUP PLC

 

Announcement to the London Stock Exchange

 

This notification is made in accordance with DTR 3.1.4(1)(a) and DTR 3.1.4(1)(b).

 

On 17 October 2012, awards over 444,198 ordinary shares in the Company were made under the Wilmington Group plc 2007 Performance Share Plan (the "Plan") to employees of the Group of which the following were made to Directors of the Company and other Persons Discharging Managerial Responsibility ("PDMRs"):

 

Name of Director/PDMR Number of shares under the Award

 

Charles Brady (Chief Executive) 122,400

Tony Foye (Executive Director) 183,111

Neil Smith (Executive Director) 93,528

Linda Wake (PDMR) 26,591

 

No consideration was paid for the grant of the award which is structured as a conditional award.

 

The vesting of an award is subject to the satisfaction of performance conditions set by the Remuneration Committee of the Company. The award will normally vest on the later of the third anniversary of grant and the determination of the performance conditions.

 

Richard Cockton

Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBSBDGLBDBGDC
Date   Source Headline
20th Feb 20237:00 amRNSHalf-year Report
9th Feb 202312:36 pmRNSHolding(s) in Company
1st Feb 20237:00 amRNSTotal Voting Rights
24th Jan 202310:30 amRNSNotice of Half Year-End Results
19th Dec 202211:32 amRNSHolding(s) in Company
12th Dec 20227:00 amRNSJoint Broker appointment
5th Dec 20224:35 pmRNSPrice Monitoring Extension
5th Dec 20222:50 pmRNSHolding(s) in Company
1st Dec 20227:00 amRNSTotal Voting Rights
23rd Nov 20223:12 pmRNSResult of AGM
15th Nov 20222:31 pmRNSHolding(s) in Company
17th Oct 202212:11 pmRNSHoling(s) in Company
17th Oct 202212:11 pmRNSHolding(s) in Company
3rd Oct 20225:52 pmRNSDirector/PDMR Shareholding
3rd Oct 20225:51 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:00 amRNSTotal Voting Rights
30th Sep 20224:42 pmRNSSecond Price Monitoring Extn
30th Sep 20224:36 pmRNSPrice Monitoring Extension
29th Sep 20223:43 pmRNSHolding(s) in Company
29th Sep 20223:36 pmRNSIssue of ordinary shares
22nd Sep 20227:00 amRNSFinancial results for the year ended 30 June 2022
31st Aug 20227:00 amRNSNotice of Results
19th Aug 20225:07 pmRNSDirector/PDMR Shareholding
1st Aug 20227:00 amRNSTotal Voting Rights
27th Jul 20227:00 amRNSYear-End Trading Update
1st Jul 20227:00 amRNSTotal Voting Rights
29th Jun 20223:04 pmRNSHolding(s) in Company
14th Jun 20227:00 amRNSTransaction in Own Shares
10th Jun 20224:36 pmRNSPrice Monitoring Extension
1st Jun 20227:00 amRNSTotal Voting Rights
26th May 20227:00 amRNSSave As You Earn Options
16th May 202211:52 amRNSSave As You Earn Options
13th May 20227:00 amRNSSave As You Earn Options
5th May 20229:39 amRNSShare Awards
3rd May 20227:00 amRNSTotal Voting Rights
1st Apr 20227:00 amRNSTotal Voting Rights
15th Mar 20227:00 amRNSTrading impact of face-to-face events
1st Mar 20227:00 amRNSTotal Voting Rights
24th Feb 20227:00 amRNSDirector/PDMR Shareholding
21st Feb 20227:00 amRNSHalf-year Report
14th Feb 202210:06 amRNSHolding(s) in Company
14th Feb 202210:00 amRNSHolding(s) in Company
1st Feb 20227:00 amRNSTotal Voting Rights
27th Jan 20227:00 amRNSTrading Update
24th Dec 202110:59 amRNSAMT Financial Training business sold for £23.4m
17th Dec 20214:40 pmRNSSecond Price Monitoring Extn
17th Dec 20214:36 pmRNSPrice Monitoring Extension
1st Dec 20217:00 amRNSTotal Voting Rights
25th Nov 202111:26 amRNSHolding(s) in Company
3rd Nov 202112:14 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.